We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 14 JANUARY 2016
Biosimilar Approvals In The US And Canada – Sidestepping The 'Patent Dance'
Smart & Biggar
Resolution of patent issues between drug companies can be the last hurdle to biosimilar market entry in some cases.
CanadaIntellectual Property




